Adenovirus Expressing Both Thymidine Kinase and Soluble PD1 Enhances Antitumor Immunity by Strengthening CD8 T-cell Response-Reference-Cited by-同舟云学术

Adenovirus Expressing Both Thymidine Kinase and Soluble PD1 Enhances Antitumor Immunity by Strengthening CD8 T-cell Response

Published:2013-03 Issue:3 Volume:21 Page:688-695
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Shin Seung-Pil,Seo Hye-Hyun,Shin Jae-Hun,Park Hyung-Bae,Lim Dong-Pyo,Eom Hyeon-Seok,Bae Yong-Soo,Kim In-Hoo,Choi Kyungho,Lee Sang-Jin

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference44 articles.

1. In vivo reprogramming of hTERT by trans-splicing ribozyme to target tumor cells;Hong;Mol Ther,2008

2. Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model;Jeong;Clin Cancer Res,2008

3. Cell cycle control pathways act as conditioning factors for TK/GCV sensitivity in pancreatic cancer cells;Abate-Daga;Biochim Biophys Acta,2010

4. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo;Chen;Proc Natl Acad Sci USA,1994

5. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system;Smythe;Cancer Res,1994

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flt3 ligand augments immune responses to soluble PD1-based DNA vaccine via expansion of type 1 conventional DCs;International Immunopharmacology;2024-11

2. Prognostic significance of soluble PD-L1 in prostate cancer;Frontiers in Immunology;2024-07-11

3. Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies;Journal of Experimental & Clinical Cancer Research;2024-05-31

4. Surface PD-1 expression in T cells is suppressed by HNRNPK through an exonic splicing silencer on exon 3;Inflammation Research;2024-05-02

5. An anti-PD-1 antisense oligonucleotide promotes the expression of soluble PD-1 by blocking the interaction between SRSF3 and an exonic splicing enhancer of PD-1 exon 3;International Immunopharmacology;2024-01